Increase of Serum Ferritin Levels During HCV Triple Therapy With Telaprevir, PEG-Interferon ALPHA-2A and Ribavirin Predicts Rrvr

被引：0
|
作者：
Zopf, Steffen
Janisch, Florian
Siebler, Juergen
Neurath, Markus F.
Janisch, Hans-Dieter
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：S980 / S980
页数：1
相关论文
共 50 条
  • [41] Attention abnormalities in chronic hepatitis c (CHC) patients during peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may persist after treatment discontinuation
    Pawelczyk, T.
    Strzelecki, D.
    Pawelczyk, A.
    Rabe-Jablonska, J.
    EUROPEAN PSYCHIATRY, 2007, 22 : S303 - S304
  • [42] Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy
    Lange, Christian M.
    Kutalik, Zoltan
    Morikawa, Kenichi
    Bibert, Stephanie
    Cerny, Andreas
    Dollenmaier, Guenter
    Dufour, Jean-Francois
    Gerlach, Tilman J.
    Heim, Markus H.
    Malinverni, Raffaele
    Muellhaupt, Beat
    Negro, Francesco
    Moradpour, Darius
    Bochud, Pierre-Yves
    HEPATOLOGY, 2012, 55 (04) : 1038 - 1047
  • [43] Chronic Hepatitis C: Peg-Interferon and /or ribavirin (PR) dose modifications during triple antiviral therapy have no impact on SVR rate: a single center experience
    Le Folgoc, Gaelle
    Oules, Valerie
    Lecomte, Laurence
    Ansaldi, Christelle
    Castellani, Paul
    Benmenni, Annie
    Riso, Aurelie
    Ben Ali, Souad
    Hernandez, Christine P.
    Siame, Sabrina
    Xavier, Adhoute
    Portal, Isabelle
    Penaranda, Guillaume
    Bourliere, Marc
    HEPATOLOGY, 2013, 58 : 1121A - 1122A
  • [44] Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy
    Derbala, M. F.
    El Dweik, N. Z.
    Al Kaabi, S. R.
    Al-Marri, A. D.
    Pasic, F.
    Bener, A. B.
    Shebl, F. M.
    Amer, A. M.
    Butt, M. T.
    Yakoob, R.
    John, A.
    Al Mohanadi, M.
    Al Khinji, M. A.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (08) : 591 - 599
  • [45] Serum lipoprotein levels during treatment of chronic hepatitis C with PEG-interferon-alpha-2a & ribavirin - A differential effect on genotype 3 patients
    Rotman, Y.
    Levi, Z.
    Hazazi, R.
    Cohen, M.
    Cohen-Ezra, O.
    Manhaim, V.
    Braun, M.
    Ben-Ari, Z.
    Tur-Kaspa, R.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S224 - S224
  • [46] Rapid Clearance Of JAK2 V617F Allele Burden In Patient With Advanced Polycythemia Vera (PV) During Combination Therapy With Ruxolitinib and Peg-Interferon Alpha-2a
    Bjorn, Mads Emil
    de Stricker, Karin
    Kjaer, Lasse
    Ellemann, Karsten
    Hasselbalch, Hans Carl
    BLOOD, 2013, 122 (21)
  • [47] Significant differences between different assays for assessment of HCV RNA undetectability during response guided therapy in patients treated with PEG-Interferon, Ribavirin with or without a protease inhibitor
    Peiffer, Kai-Henrik
    Gerber, Ludmila
    Susser, Simone
    Vermehren, Johannes
    Perner, Dany
    Sarrazin, Christoph
    HEPATOLOGY, 2012, 56 : 560A - 560A
  • [48] THE ASSOCIATION BETWEEN HAEMOGLOBIN DECLINE AND SVR IS INDEPENDENT OF ITPA GENOTYPE DURING PEG-INTERFERON PLUS RIBAVIRIN THERAPY FOR HCV-1: ANALYSIS FROM THE CHARIOT STUDY
    Holmes, J. A.
    Bonanzinga, S.
    Roberts, S. K.
    Sievert, W.
    Dore, G. J.
    McCaughan, G.
    Crawford, D. H.
    Cheng, W. S.
    Weltman, M. D.
    Matthews, G.
    Visvanathan, K.
    Sundararajan, V.
    Desmond, P. V.
    Bowden, D. S.
    Thompson, A. J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S189 - S190
  • [49] Effect of gender and ITPA polymorphism (rs6051702) on anemia in chronic HCV genotype 1 and 4 patients treated with peg-interferon alpha 2a and ribavirin
    Scherzer, Thomas-Matthias
    Laferl, Hermann
    Maieron, Andreas
    Schwarzer, Remy
    Strasser, Michael P.
    Stauber, Rudolf E.
    Datz, Christian
    Staettermayer, Albert
    Beinhardt, Sandra
    Rutter, Karoline
    Steindl-Munda, Petra E.
    Hofer, Harald
    Ferenci, Peter
    HEPATOLOGY, 2012, 56 : 1027A - 1027A
  • [50] Induction-dose of PEG-interferon alfa-2b in combination with ribavirin in HCV-non-responders to prior interferon or interferon-ribavirin combination therapy: Results of a French multicenter RIBAPEG-NR trial
    Rosa, I
    Hagege, H
    Auray-Cartier, V
    Cassan, P
    Wartelle, C
    Denis, J
    Arpurt, JP
    Nouel, O
    Gargot, D
    Nalet, B
    Pariente, A
    Chousterman, M
    GASTROENTEROLOGY, 2004, 126 (04) : A430 - A430
12345